LegalView Launches Byetta Information Portal to Provide Patients with the Details of Diabetes Drug Dangers

Denver, CO — LegalView launched its new Byetta information portal to offer details of potential Byetta side effects of taking the type 2 diabetes drug. In August, the U.S. Food and Drug Administration (FDA) announced it would increase warning labeling regarding Byetta after several patients were hospitalized and two patients died because of life-threatening pancreas issues, allegedly linked to Byetta. Patients who are taking Byetta should consult with their doctor and may want to consider speaking with an experienced pharmaceutical attorney who can provide insight into developing a potential Byetta class action in which monetary compensation might be awarded.

Byetta (exanatide), which treats type 2 diabetes, was approved for market in August 2005 from makers Amilyn Pharmaceuticals and Eli Lilly and Company. The drug is an injectable medicine that controls glucose (blood sugar) levels among adults with diabetes. According to news reports, the FDA had nearly 30 reports of acute pancreatitis recently, from as early as October 2007. Those wishing to know more about the possible Byetta risks can use the Legalview resource to contact a pharmaceutical law firm that can offer an experienced Byetta lawyer to help understand potential litigation.

In addition to the details of the Byetta risks, LegalView also offers readers several other pharmaceutical information portals on topics such as Avandia, Ketek and the Zimmer Durom cups.

Avandia, which is similar to Byetta, is a type 2 diabetes drug that has been under a wave of controversy after several medical studies linked the drug to heart failure and early onset osteoporosis among patients. The drug continues to remain on the market, even though the FDA acknowledged the serious potential risks of heart failure among Avandia patients. To learn more about the Avandia side , it is advised to speak with a medical professional.

The Ketek controversy occurred after approximately 18 deaths and 100 cases of liver damage reportedly occurred among patients taking the antibiotic. Ketek treats bacterial infections and upper respiratory conditions and has been available in the United States since 2004. The FDA has not issued a Ketek recall but is aware of the potential increase of liver disease and liver damage among Ketek patients and is currently investigating the drug.

The Durom cup, from Zimmer Holdings, is an artificial hip socket used in hip replacement surgeries. However, reports began flooding in from physicians across the country that the hip socket was failing in many of the 12,000 patients who have received the hip socket. To learn more about the Zimmer Durom cup contact a knowledgeable medical device attorney and who can assist in learning about the potential for receiving monetary compensation in case a Zimmer Durom cup lawsuit is developed.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.